Ceragenix Appoints Former President of Boston Scientific-Europe and Former President of Baxter Healthcare-Asia to Board of Directors
16 juin 2005 08h30 HE
|
Ceragenix Pharmaceuticals
DENVER, June 16, 2005 (PRIMEZONE) -- OnSource Corporation (OTCBB:OSCE) d/b/a Ceragenix Pharmaceuticals ("Ceragenix" or the "Company"), has appointed four independent directors -- adding significant...
Ceragenix Appoints Russell Allen Vice President of Corporate Development
15 juin 2005 08h30 HE
|
Ceragenix Pharmaceuticals
DENVER, June 15, 2005 (PRIMEZONE) -- OnSource Corporation (OTCBB:OSCE) d/b/a Ceragenix Pharmaceuticals ("Ceragenix" or the "Company"), has named Russell L. Allen its new Vice President of Corporate...
Ceragenix Pharmaceuticals to File 510k for Reformulation of Epiceram
23 mai 2005 16h15 HE
|
Ceragenix Pharmaceuticals
DENVER, May 23, 2005 (PRIMEZONE) -- OnSource Corporation (OTCBB:OSCE), d/b/a Ceragenix Pharmaceuticals ("Ceragenix" or the "Company"), has withdrawn its pending Request for Designation from the...
Osmotics Pharma, Inc. and OnSource Corporation Complete Merger
11 mai 2005 08h30 HE
|
Ceragenix Pharmaceuticals
DENVER, May 11, 2005 (PRIMEZONE) -- OnSource Corporation ("OnSource") (OTCBB:OSCE) has completed its planned merger with Osmotics Pharma, Inc. ("OPI"), a specialty pharmaceutical company focused on...